Acticlate Capsule
Product Images NDC 16110-601

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Acticlate (NDC 16110-601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aqua Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Acticlate Cap 01)

FDA Label Image

150mg Treatment (Acticlate Cap 02)

FDA Label Image

150mg Treatment (Acticlate Cap 03)

FDA Label Image

150mg Treatment (Acticlate Cap 04)

150mg Treatment (Acticlate Cap 04)
The text describes the views of a one-third tablet, from a top view and two side views, one of them showing how it can be held with the thumb and index finger. No further information is provided.*
FDA Label Image

75 mg Capsule 60-count Bottle Label (Acticlate Cap 05)

75 mg Capsule 60-count Bottle Label (Acticlate Cap 05)
This is a medication called Acticlate CAP, which is used to treat certain bacterial infections. Each capsule contains 86.6 mg of doxycycline hyclate, equivalent to 1075 mg of doxycycline. Dosage and storage information can be found on the package insert, and the medication should be stored in a tightly sealed, light-resistant container at a temperature between 20°C - 25°C (68°F - 77°F). The medication is manufactured by Catalent Pharma Solutions in Winchester, Kentucky and is distributed by Aqua Pharmaceuticals, an Almirall Company in Exton, Pennsylvania. The medication is only available with a prescription and the packaging includes a National Drug Code (NDC) number of 16110-601-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.